Avinger, Inc. announced that Thomas J. Fogarty, has been elected to it's board of directors, effective December 31, 2014. He is currently the chairman of the Fogarty Institute for Innovation and also serves as a managing director of Emergent Medical Partners, a life sciences investment firm that focuses on medical device and healthcare companies. Previously, Fogarty has held positions as president, Medical Staff at Stanford University Medical Center, and director, Cardiovascular Surgery at Sequoia Medical Center.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 USD | +8.21% | +7.86% | +51.64% |
Mar. 20 | Avinger, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 20 | Earnings Flash (AVGR) AVINGER Posts Q4 Revenue $1.9M, vs. Street Est of $2.52M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.64% | 6.02M | |
-1.71% | 14.91B | |
-34.43% | 2.96B | |
-13.40% | 2.41B | |
-12.18% | 1.48B | |
-.--% | 1.12B | |
+62.40% | 583M | |
+13.87% | 244M | |
+0.70% | 230M | |
+7.22% | 188M |
- Stock Market
- Equities
- AVGR Stock
- News Avinger, Inc.
- Avinger, Inc. Appoints Thomas J. Fogarty, to it's Board of Directors